Vincerx Pharma (VINC) News Today $0.66 +0.03 (+4.73%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.62 -0.03 (-5.27%) As of 04:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Vincerx Pharma (VINC) to Release Earnings on FridayApril 2 at 1:06 AM | americanbankingnews.comVincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Down 64.1% in MarchMarch 27, 2025 | americanbankingnews.comVincerx Pharma announces non-binding LOI for Qumulus AI combinationMarch 18, 2025 | markets.businessinsider.comVincerx Pharma, Inc.: Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAIMarch 18, 2025 | finanznachrichten.deVincerx Pharma Shares Soar on Proposed Merger with Global Digital HoldingsMarch 18, 2025 | marketwatch.comVincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAIMarch 18, 2025 | globenewswire.comVincerx Pharma announces termination of reverse merger term sheetMarch 1, 2025 | markets.businessinsider.comVincerx Pharma Terminates Reverse Merger Deal With OqoryMarch 1, 2025 | marketwatch.comVincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic AlternativesFebruary 28, 2025 | globenewswire.comVINC stock touches 52-week low at $1.3 amid market challengesFebruary 12, 2025 | msn.comVINC stock touches 52-week low at $1.62 amid market challengesJanuary 30, 2025 | msn.comVincerx Pharma and Oqory reveal merger and cancer drug dataJanuary 30, 2025 | msn.comVincerx Pharma, Inc. (NASDAQ:VINC) Short Interest UpdateVincerx Pharma, Inc. (NASDAQ:VINC - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 4,710,000 shares, an increase of 1,022.5% from the December 31st total of 419,600 shares. Based on an average daily trading volume, of 6,840,000 shares, the short-interest ratio is currently 0.7 days.January 29, 2025 | marketbeat.comVincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258January 29, 2025 | markets.businessinsider.comVincerx Pharma Inc trading halted, news pendingJanuary 28, 2025 | markets.businessinsider.comVincerx Pharma files $100M mixed securities shelfJanuary 24, 2025 | markets.businessinsider.comPalo Alto's Vincerx Pharma plans reverse stock split amid merger plansJanuary 24, 2025 | bizjournals.comVincerx Pharma board aproves 1-for-20 reverse stock splitJanuary 24, 2025 | markets.businessinsider.comVincerx Pharma, Inc. Announces Reverse Stock SplitJanuary 23, 2025 | investing.comVincerx Pharma, Inc. Announces Reverse Stock SplitJanuary 23, 2025 | globenewswire.comVincerx Pharma enters at-the-market equity offering dealJanuary 21, 2025 | msn.comVincerx Pharma Inc Ordinary SharesJanuary 14, 2025 | morningstar.comInvestor law firms question biotech merger's 'fairness'January 7, 2025 | bizjournals.comVINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINCJanuary 6, 2025 | businesswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vincerx Pharma, Inc. MergerJanuary 3, 2025 | markets.businessinsider.comVINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to ShareholdersDecember 30, 2024 | businesswire.comShareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public ShareholdersDecember 30, 2024 | businesswire.comVincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains BullishDecember 30, 2024 | msn.comVincerx Pharma, Inc.: Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.December 28, 2024 | finanznachrichten.deVincerx Pharma To Merge With Oqory; Cuts JobsDecember 28, 2024 | markets.businessinsider.comVincerx Pharma enters binding term sheet for merger with OqoryDecember 27, 2024 | markets.businessinsider.comVincerx Pharma To Be Acquired by Private Biotech, Cut HeadcountDecember 27, 2024 | marketwatch.comVincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.December 27, 2024 | globenewswire.comVincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug TrialsDecember 5, 2024 | msn.comVincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943December 4, 2024 | globenewswire.comVincerx Pharma Inc: Strategic Advancements and Promising Pipeline Highlight Buy RatingNovember 14, 2024 | markets.businessinsider.comVincerx Pharma, Inc.: Vincerx Pharma Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deVincerx Pharma Reports Q3 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comVincerx Pharma: A Strong Buy on Promising VIP943 Clinical Results and Strategic FocusOctober 9, 2024 | markets.businessinsider.comPenny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer CandidatesOctober 8, 2024 | benzinga.comVincerx Reports Positive Initial Clinical Data From VIP943 Phase 1 Dose-Escalation StudyOctober 8, 2024 | markets.businessinsider.comVincerx Pharma (NASDAQ:VINC) Stock, Insider Trading ActivityOctober 7, 2024 | benzinga.comVincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate UpdatesOctober 7, 2024 | globenewswire.comVincerx Pharma (NASDAQ:VINC) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comCompanies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite RiskyAugust 21, 2024 | finance.yahoo.comBuy Rating Affirmed for Vincerx Pharma Amid Positive Clinical Progress and Stable Financial OutlookAugust 14, 2024 | markets.businessinsider.comVINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024August 9, 2024 | investorplace.comVincerx Pharma Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 | globenewswire.comVincerx Pharma GAAP EPS of -$0.58May 15, 2024 | msn.comVincerx Pharma, Inc.: Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | finanznachrichten.de Remove Ads Get Vincerx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter. Email Address VINC Media Mentions By Week VINC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VINC News Sentiment▼0.490.61▲Average Medical News Sentiment VINC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VINC Articles This Week▼11▲VINC Articles Average Week Remove Ads Get Vincerx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OGEN News Today CMND News Today APM News Today ADIL News Today ALLR News Today SONN News Today EVOK News Today GLTO News Today CNSP News Today KZIA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VINC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VINC Stock Free VINC Stock Alerts